posit
control
prepar
posit
cdv
cpiv
obtain
modifiedl
vaccin
plu
zoeti
kalamazoo
mi
usa
contain
cpiv
cdv
meanwhil
posit
crcov
civ
deriv
natur
infect
dog
confirm
nucleic
acid
sequenc
civ
posit
kindli
provid
prof
alongkorn
amornsin
depart
veterinari
public
health
faculti
veterinari
scienc
chulalongkorn
univers
specimen
nasal
ns
oropharyng
swab
os
collect
suspect
cirdc
suffer
dog
brought
veterinari
hospit
resid
metropolitan
bangkok
thailand
februaryaugust
dog
show
respiratori
problem
nasal
discharg
cough
evid
bronchopneumonia
includ
wherea
reveal
secondari
respiratori
diseas
caus
cardiovascular
andor
function
tracheal
diseas
exclud
studi
vaccin
statu
sampl
dog
also
record
take
ns
os
use
steril
rayon
tip
applic
guifolrd
usa
swab
immers
phosphat
buffer
salin
pb
kept
assay
studi
protocol
approv
chulalongkorn
univers
anim
care
use
committe
viral
nucleic
acid
extract
quantif
revers
transcript
viral
nucleic
acid
posit
control
specimen
extract
use
viral
nucleic
acid
extract
kit
ii
geneaid
taipei
taiwan
accord
manufactur
recommend
nucleic
acid
quantifi
qualifi
use
lite
thermo
fisher
scientif
inc
waltham
usa
absorb
nm
deriv
ratio
extract
nucleic
acid
divid
two
aliquot
one
revers
transcript
rt
detect
rna
virus
civ
cpiv
cdv
crcov
direct
pcr
assay
detect
dna
virus
rt
perform
use
ng
rna
templat
complementari
dna
cdna
synthesi
use
revers
transcript
kit
qiagen
gmbh
hilden
germani
cdna
dna
store
use
pcr
amplif
specif
primer
virus
caus
cirdc
sequenc
primer
use
gene
cdv
np
gene
civ
gene
cpiv
np
gene
crcov
gene
gb
gene
amplif
retriev
previou
studi
shown
tabl
order
ascertain
sensit
specif
interact
primer
sequenc
target
gene
compar
multipl
align
use
bioedit
sequenc
align
editor
version
ibi
bioscienc
carlsbad
ca
usa
silico
specif
test
perform
select
conserv
region
use
blastn
analysi
order
ensur
primer
specif
without
cross
amplif
canin
gene
degener
primer
civ
cdv
crcov
appli
tabl
moreov
canin
dehydrogenas
gapdh
gene
use
intern
control
report
previous
optim
simplex
pcr
prior
perform
pcr
detect
rna
virus
first
round
pcr
crcov
perform
order
increas
detect
sensit
reaction
compris
mixtur
hot
start
green
master
mix
promega
madison
wi
usa
final
concentr
outer
primer
cdna
made
nucleasefre
water
reaction
perform
use
g
gradient
thermal
cycl
techn
bristol
uk
cycl
condit
compris
initi
denatur
min
follow
cycl
sec
sec
sec
final
extens
perform
min
subsequ
amplifi
crcov
product
first
round
pcr
cdna
rna
virus
civ
cpiv
cdv
extract
dna
virus
use
templat
simplex
pcr
studi
gradient
simplex
pcr
perform
viru
reaction
composit
mention
gradient
anneal
temperatur
ta
program
rang
order
optim
reaction
thermal
cycl
perform
min
cycl
min
vari
ta
min
min
final
min
amplicon
resolv
wv
agaros
gel
electrophoresi
ethidium
bromid
ingel
stain
visual
uv
transillumin
compar
expect
size
pcr
product
tabl
optim
multiplex
pcr
multiplex
pcr
optim
separ
rna
dnaassoci
cirdc
virus
start
genet
materi
rna
viru
detect
deriv
two
compart
product
first
nest
pcr
crcov
cdna
rna
virus
reaction
composit
condit
optim
mention
simplex
pcr
suitabl
ta
rna
dna
virus
select
compar
analysi
simplex
pcr
sequenc
pcr
amplicon
perform
confirm
correct
ident
thu
specif
pcr
reaction
amplicon
purifi
nucleospin
extract
ii
machereynagel
germani
kit
submit
base
pte
ltd
singapor
direct
sequenc
deriv
nucleotid
sequenc
align
use
bioedit
sequenc
align
editor
version
softwar
respect
consensu
sequenc
compar
genbank
databas
use
blastn
analysi
analysi
specif
sensit
reproduc
specif
test
analyt
specif
simplex
pcr
assay
evalu
crossreact
test
variou
cirdcassoci
virus
well
canin
parvoviru
cpv
canin
enter
coronaviru
ccov
bordetella
bronchiseptica
sensit
test
access
analyt
sensit
simplex
pcr
assay
twofold
serial
dilut
nucleic
extract
posit
control
amplifi
ten
dilut
test
control
pcr
reaction
reproduc
intra
interassay
variat
measur
use
posit
control
sequenc
clinic
sampl
assess
intraassay
variat
triplic
amplif
templat
posit
control
sampl
perform
singl
multiplex
pcr
assay
evalu
interassay
variat
singl
multiplex
pcr
perform
three
independ
multiplex
pcr
assay
diagnost
perform
multiplex
pcr
evalu
reliabl
develop
multiplex
pcr
clinic
test
perform
assay
compar
simplex
pcr
commerci
test
kit
antigen
rapid
ag
test
kit
bionot
hwaseong
south
korea
sensit
specif
posit
predict
valu
neg
predict
valu
determin
independ
ttest
use
evalu
differ
rout
sampl
collect
number
viral
detect
use
spss
ibm
corp
new
york
ny
usa
studi
popul
dog
respiratori
clinic
ill
includ
studi
male
femal
dog
puppi
senil
present
nasal
discharg
cough
loss
appetit
bronchopneumonia
dog
vaccin
optim
analyt
perform
simplex
multiplex
pcr
assay
optim
simplex
pcr
undertaken
use
posit
control
clinic
sampl
differ
cycl
condit
differ
anneal
temperatur
evalu
optimum
ta
viru
detect
temperatur
primer
dimer
nonspecif
amplicon
detect
data
shown
silico
vitro
analyt
specif
test
reveal
primer
abl
amplifi
specif
target
dna
without
cross
amplif
among
cirdc
virus
cpv
ccov
b
bronchiseptica
addit
sequenc
amplicon
show
sequenc
ident
respect
correspond
sequenc
genbank
databas
analyt
sensit
specif
reproduc
sensit
multiplex
pcr
test
detect
variou
virus
serial
dilut
compar
use
simplex
pcr
particular
viru
multiplex
pcr
product
test
virus
observ
templat
dilut
simplex
pcr
suggest
similar
sensit
simplex
multiplex
pcr
fig
highest
detect
threshold
found
cdv
crcov
civ
final
cpiv
specif
test
pcr
evalu
use
pathogen
mention
specif
amplicon
detect
reaction
evalu
reproduc
intra
interassay
variat
reveal
similar
result
among
assay
data
shown
evalu
multiplex
pcr
use
clinic
specimen
multiplex
pcr
test
ns
os
sampl
fig
compar
simplex
pcr
assay
respect
viru
tabl
crcov
detect
sensit
specif
ns
os
sampl
site
fals
neg
result
observ
civ
cpiv
cdv
detect
perform
multiplex
pcr
result
lower
sensit
ppv
multiplex
pcr
consist
specif
npv
reaction
contrari
sensit
neither
multiplex
rtpcr
multiplex
pcr
show
fals
posit
result
compar
simplex
counterpart
comparison
multiplex
pcr
rapid
threeantigen
test
kit
civ
cdv
perform
sampl
tabl
clinic
sampl
test
studi
rapid
test
kit
yield
sensit
rel
high
specif
cdv
howev
civ
high
number
pcrposit
sampl
detect
multiplex
pcr
wherea
test
kit
show
neg
result
detect
cirdc
virus
clinic
sampl
multiplex
pcr
singl
infect
civ
predomin
viru
detect
account
posit
ns
os
sampl
respect
next
common
viru
cpiv
detect
ns
os
sampl
respect
posit
crcov
infect
ns
os
sampl
even
though
cdv
detect
singl
infect
detect
multipl
infect
test
sampl
tabl
dual
infect
frequent
detect
virus
civ
coinfect
crcov
ns
os
respect
follow
civ
cpiv
ns
os
sampl
respect
tripl
infect
civ
crcov
frequent
found
togeth
coinfect
virus
especi
cdv
cpiv
howev
one
dog
neg
test
virus
ns
os
sampl
gener
dual
infect
predomin
cirdc
suffer
dog
follow
singl
tripl
infect
regard
sampl
site
frequenc
posit
result
statist
differ
os
ns
sampl
site
p
cirdc
import
diseas
impact
dog
especi
puppi
immunosuppress
dog
frequent
associ
viral
infect
gain
attent
recent
mani
virus
discov
coinfect
multipl
pathogen
often
fatal
thu
develop
diagnost
tool
cirdcassoci
viru
detect
necessari
enhanc
diagnosi
coverag
studi
multiplex
rtpcr
multiplex
pcr
detect
cirdcassoci
rna
dna
virus
respect
develop
compar
convent
method
develop
multiplex
pcr
could
detect
sever
virus
associ
cirdc
effici
two
multiplex
pcr
gave
similar
result
equival
obtain
convent
simplex
pcr
could
detect
one
pathogen
per
reaction
requir
six
separ
reaction
per
sampl
nest
amplif
perform
crcov
detect
order
increas
sensit
detect
poovorawan
person
commun
although
multiplex
pcr
develop
previous
detect
sever
pathogen
cirdc
civ
cdv
crcov
applic
remain
limit
narrow
rang
virus
cover
cirdcassoci
virus
neither
detect
rule
thu
studi
might
provid
novel
platform
whole
cirdcviru
detect
overal
sensit
multiplex
rtpcr
multiplex
pcr
respect
compar
simplex
counterpart
howev
detect
crcov
modifi
heminest
rtpcr
increas
sensit
fals
neg
reaction
perform
multiplex
pcr
studi
might
result
select
singl
optim
ta
sever
primer
pair
low
amount
particular
target
gene
suggest
decreas
sensit
develop
multiplex
pcr
moreov
specif
modal
clinic
sampl
detect
thu
platform
could
like
use
effect
practic
recent
multiplex
pcr
assay
develop
order
detect
cirdc
pathogen
howev
test
might
immatur
civ
cdv
crcov
could
detect
other
thu
studi
expand
coverag
cirdc
viru
detect
evalu
commerci
avail
threeantigen
rapid
test
kit
civ
cdv
found
civ
detect
show
unexpect
sensit
specif
previou
studi
report
develop
multiplex
rtpcr
civ
cdv
crcov
detect
almost
sensit
specif
compar
convent
rtpcr
rapid
antigen
test
kit
contrast
studi
show
civposit
sampl
multiplex
rtpcr
neg
test
rapid
antigen
test
kit
consist
report
mani
rapid
test
kit
might
low
sensit
detect
influenza
viru
could
still
suitabl
rapid
inhous
clinic
applic
reflect
type
kit
viral
copi
number
durat
storag
rout
sampl
collect
type
viru
strain
may
influenc
test
result
interestingli
studi
sampl
clinic
respiratori
ill
dog
found
multipl
infect
find
support
symptomat
cirdc
complex
diseas
mostli
caus
coinfect
one
pathogen
recent
jeoung
et
al
use
ns
whole
blood
sampl
cirdc
viru
detect
found
cdv
civ
crcov
could
detect
whole
blood
sampl
correspondingli
respiratori
swab
report
appropri
sampl
detect
respiratori
pathogen
thu
ns
os
serv
appropri
sampl
sourc
studi
due
eas
noninvas
sampl
natur
lie
viral
shed
rout
studi
also
suggest
viru
screen
ns
os
detect
level
site
depend
type
viru
mostli
replic
lower
respiratori
tract
shed
via
respiratori
discharg
consist
find
mostli
detect
os
even
though
ns
could
often
detect
virus
well
howev
primer
pair
use
studi
abl
amplifi
dna
viru
also
show
airborn
transmiss
replic
tonsil
therefor
posit
pcr
reaction
canin
adenoviru
could
discrimin
studi
addit
latent
variou
nerv
ganglion
result
neg
result
nucleic
acidbas
detect
respiratori
discharg
nonsymptomat
dog
studi
vaccin
dog
receiv
least
combin
vaccin
cpiv
cdv
show
pcr
posit
result
cirdc
viru
detect
cdv
posit
dog
cpiv
posit
dog
even
though
live
attenu
vaccin
give
fals
posit
result
molecular
test
essenti
discrimin
wildtyp
infect
recent
vaccin
prevent
fals
posit
futur
studi
document
crcov
circul
thailand
first
time
civ
discov
thailand
dog
flulik
symptom
civ
crcov
frequent
detect
virus
cirdcinfect
dog
suggest
virus
might
spread
rapidli
virus
found
singl
infect
also
found
coinfect
togeth
virus
studi
also
exhibit
higher
level
infect
compar
previou
report
although
might
caus
differ
time
sampl
collect
popul
size
locat
howev
previous
report
infect
crcov
cpiv
might
facilit
initi
diseas
subsequ
enhanc
entri
pathogen
preval
infect
dog
increas
moreov
found
dog
infect
civ
cpiv
cdv
crcov
show
greater
sever
clinic
symptom
mark
bronchopneumonia
sudden
death
data
shown
find
consist
investig
suggest
coinfect
might
augment
sever
clinic
symptom
thu
advanc
geneticbas
detect
method
multiplex
pcr
assay
consid
altern
diagnost
platform
panel
suspect
cirdc
caus
virus
high
sensit
specif
cost
benefit
practic
usag
develop
multiplex
pcr
assay
suitabl
screen
test
diseas
diagnosi
quarantin
prevent
measur
especi
develop
countri
